Welcome to Lawsuit.com
Our mission is to provide each client with the most effective ethical representation possible, and to preserve and promote the civil justice system.
Warning on Fentora Buccal Tablets
Posted on April 29, 2008
FDA is warning healthcare professionals about deaths and patient injuries from Fentora (fentanyl buccal tablets) a drug used to treat breakthrough cancer pain.
Some of these events occurred because the drug was prescribed for patients who should not have received it. Fentora should only be used for breakthrough pain in opioid-tolerant cancer patients who are already taking around-the-clock opioids. Life-threatening respiratory depression can occur if the drug is used in patients who are not opioid-tolerant, and so it should not be prescribed for acute or postoperative pain, migraines, headaches, or pain due to injuries.
Other adverse events occurred because the dosing instructions in the product labeling were not followed. The labeling states that if the breakthrough pain episode is not relieved within 30 minutes of the first dose, patients may take only one additional tablet of the same strength for that episode. If the breakthrough pain continues even after the second dose, no more Fentora may be used for that episode. In other words, patients should never take more than two doses of Fentora to treat an episode of breakthrough pain. And they must wait a minimum of four hours after the second dose before treating another episode of breakthrough pain.
Adverse events also occurred when prescribers or pharmacists substituted Fentora for Actiq without adjusting the dose. Actiq is an oral transmucosal product containing fentanyl, but its bioavailability is lower than Fentora. So Fentora cannot be substituted for Actiq on a mcg-for-mcg basis. In making the switch from Actiq to Fentora, the dose must be adjusted downward by following the table in the product label.
Additional Information:
FDA MedWatch Safety Alert. Fentora (fentanyl buccal tablet). September 13, 2007.
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Fentora
FDA Press Release. FDA Warns of Potential Serious Side Effects with Breakthrough Cancer Pain Drug. September 26, 2007.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01711.html
Lawsuit Membership
Law firms interested in becoming part of this unique legal community should apply here.
Lawsuit Video Tips
To become a participating member of Lawsuit.com you must supply a video about your firm, talk about the litigation you find important, and how you help your clients. For ideas and video tips on effective videos click here. 
Become an Editor
Lawsuit.com is currently building one of the largest human-edited legal video databases in the Web 2.0 World. Want to help? Apply here to become an Editor.
Find a Fentora Buccal Attorney
Fill out the form below to start your claim:
Firm of the Month
April 2008 - Personal Injury California
Stanton T. Mathews & Associates
has built its practice on representing and fighting for the rights of accident victims in Laguna Hills, California and the surrounding Counties of Central Orange, Los Angeles, San Diego, Riverside and San Bernardino. With over 64 years of combined personal injury legal experience; the personal injury lawyers at Stanton T. Mathews & Associates have the experience and ability to provide personal injury/accident legal solutions to the residents of Laguna Hills, California and throughout the entire State of California.
